[go: up one dir, main page]

BR0112685A - Composição nutricional - Google Patents

Composição nutricional

Info

Publication number
BR0112685A
BR0112685A BR0112685-7A BR0112685A BR0112685A BR 0112685 A BR0112685 A BR 0112685A BR 0112685 A BR0112685 A BR 0112685A BR 0112685 A BR0112685 A BR 0112685A
Authority
BR
Brazil
Prior art keywords
composition
balance
nutritional composition
bacterial infection
pathogenic bacterial
Prior art date
Application number
BR0112685-7A
Other languages
English (en)
Inventor
Florence Rochat
Olivier Ballevre
Alfred Jann
Original Assignee
Produits Nestel S A Soc D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Produits Nestel S A Soc D filed Critical Produits Nestel S A Soc D
Publication of BR0112685A publication Critical patent/BR0112685A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Grain Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMPOSIçãO NUTRICIONAL". Uma composição nutricional é descrita que compreende carboidratos funcionais sinérgicos para a prevenção ou tratamento de infecção por bactérias patogênicas e/ou promoção de saúde e equilíbrio da flora do intestino. Os carboidratos têm uma atividade sinérgica na promoção de bifidobactérias no intestino. Também descritos são um método de produção da composição; uso da composição na fabricação de um medicamento ou alimento funcional para a prevenção ou tratamento de infecção por bactérias patogênicas e/ou promoção de saúde e equilíbrio da flora do intestino; e um método de tratamento de infecção por bactérias patogênicas e/ou promoção de saúde e equilíbrio da flora do intestino que compreende a administração de uma quantidade eficaz da composição.
BR0112685-7A 2000-07-24 2001-07-17 Composição nutricional BR0112685A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00115850A EP1175905A1 (en) 2000-07-24 2000-07-24 Nutritional Composition
PCT/EP2001/008283 WO2002007533A2 (en) 2000-07-24 2001-07-17 Nutritional composition

Publications (1)

Publication Number Publication Date
BR0112685A true BR0112685A (pt) 2003-06-24

Family

ID=8169332

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0112685A BRPI0112685B1 (pt) 2000-07-24 2001-07-17 composição nutricional para prevenção ou tratamento de infecção por bactéria potogênica, e uso de carboidratos
BR0112685-7A BR0112685A (pt) 2000-07-24 2001-07-17 Composição nutricional

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0112685A BRPI0112685B1 (pt) 2000-07-24 2001-07-17 composição nutricional para prevenção ou tratamento de infecção por bactéria potogênica, e uso de carboidratos

Country Status (22)

Country Link
US (2) US20030166610A1 (pt)
EP (4) EP1175905A1 (pt)
JP (1) JP4955896B2 (pt)
KR (1) KR20030041962A (pt)
CN (1) CN100349575C (pt)
AT (1) ATE485827T1 (pt)
AU (1) AU2001289680A1 (pt)
BG (1) BG107473A (pt)
BR (2) BRPI0112685B1 (pt)
CA (1) CA2416990C (pt)
CZ (1) CZ2003535A3 (pt)
DE (1) DE60143356D1 (pt)
DK (1) DK1305036T3 (pt)
ES (2) ES2355754T3 (pt)
HU (1) HUP0303728A3 (pt)
IL (1) IL153989A (pt)
MX (1) MXPA03000742A (pt)
NO (1) NO20030316L (pt)
PL (1) PL366049A1 (pt)
PT (1) PT1305036E (pt)
WO (1) WO2002007533A2 (pt)
ZA (1) ZA200301401B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2815824B1 (fr) * 2000-10-31 2003-04-25 Colloides Naturels Internat Methode et preparation de type fibre alimentaire soluble bifidogene pour la mise en oeuvre de ladite methode
AU2002331469B2 (en) 2001-08-20 2008-04-24 Cargill, Incorporated Non-starch-polysaccharides
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
FR2848783B1 (fr) * 2002-12-18 2005-05-13 Agronomique Inst Nat Rech Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
US20070207132A1 (en) * 2003-10-24 2007-09-06 N.V. Nutricia Synbiotic Composition For Infants
US8148351B2 (en) 2003-12-12 2012-04-03 Taiyo Kagaku Co., Ltd. Enteropathy ameliorating composition
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
ES2524344T3 (es) * 2005-02-28 2014-12-05 N.V. Nutricia Composición nutritiva con probióticos
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AU2006220682B2 (en) 2005-03-07 2012-05-31 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
CA2865661C (en) 2007-03-29 2016-05-17 Progenics Pharmaceuticals, Inc. Peripheral opioid receptor antagonists and uses thereof
EP2134718A2 (en) 2007-03-29 2009-12-23 Progenics Pharmaceuticals, Inc. Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
EP2565195B1 (en) 2007-03-29 2015-05-06 Wyeth LLC Peripheral opioid receptor and antagonists and uses thereof
GB0718974D0 (en) 2007-09-28 2007-11-07 Univ Leuven Kath oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
US20110009359A1 (en) * 2007-12-21 2011-01-13 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
WO2009099411A1 (en) 2008-02-06 2009-08-13 Progenics Pharmaceuticals, Inc. Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone
AU2009225434B2 (en) 2008-03-21 2014-05-22 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
GB0805360D0 (en) 2008-03-25 2008-04-30 Univ Leuven Kath Arabinoxylan oligosaccharide preparation
PT2348890E (pt) 2008-03-28 2013-09-26 Nestec Sa Probióticos para utilização em fêmeas de mamíferos gestantes para reforçar a imunidade da sua descendência
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
ES2545597T3 (es) 2009-11-12 2015-09-14 Nestec S.A. Composición nutritiva para fomentar el equilibrio de la flora intestinal y para fomentar la salud
KR101421807B1 (ko) * 2012-09-28 2014-07-22 주식회사 포스코 코크스 오븐의 타르 제거장치
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
CN103704472B (zh) * 2013-12-13 2016-03-23 山东星光生物科技有限公司 一种低聚果糖功能性浓缩饲料及其制备方法
CN105828641A (zh) 2013-12-20 2016-08-03 雀巢产品技术援助有限公司 用于减少肠病原体的营养组合物
CN104920809B (zh) * 2014-03-18 2018-02-23 中国科学院大连化学物理研究所 一种改善母猪奶水中乳汁寡糖的饲料添加剂预混剂及其使用方法
JP2017513953A (ja) * 2014-04-25 2017-06-01 ネキシラ インターナショナル 腸内不浸透性を改善するためのアラビアゴム（ａｇ）を含む組成物の利用
KR102538288B1 (ko) * 2014-10-03 2023-05-31 가부시키가이샤 메이지 올리고당 제제 및 그 제조 방법
CN104939082A (zh) * 2015-06-02 2015-09-30 西安膳方医药科技有限公司 一种复合益生元及其制备方法
EA035945B1 (ru) * 2015-08-04 2020-09-04 Зюдцукер АГ Профилактическое использование инулина от синусита
WO2017027601A1 (en) * 2015-08-11 2017-02-16 Shaklee Corporation Materials and methods for improving gastrointestinal health
TW201826948A (zh) * 2017-01-13 2018-08-01 美商通路實業集團國際公司 膳食益生增補品及其相關方法
CN108902970A (zh) * 2018-06-27 2018-11-30 安徽瑞康食品生物科技有限公司 含有戊聚糖的食用组合物，功能食品及其制备方法、用途
CN109315728A (zh) * 2018-09-19 2019-02-12 北京爱仁医疗科技有限公司 一种含有虾青素的食品及其在肠道菌群调节中的应用
WO2022083858A1 (en) * 2020-10-21 2022-04-28 Compagnie Gervais Danone Acacia gum for iron induced microbial dysbiosis
CA3234064A1 (en) * 2021-10-22 2023-04-27 Willy JOLY Nucleotides and oligosaccharides for use as food composition
JP7513327B1 (ja) 2023-09-01 2024-07-09 株式会社feileB 固形製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
ES2123903T5 (es) * 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
CA2198681C (en) * 1996-03-01 2004-10-26 Sherianne James Method for producing fat-free and low-fat viscous dressings using inulin
US5952033A (en) * 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP4273277B2 (ja) * 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物

Also Published As

Publication number Publication date
ES2650122T3 (es) 2018-01-17
JP2004504332A (ja) 2004-02-12
EP2255815B1 (en) 2017-10-25
CZ2003535A3 (cs) 2003-09-17
NO20030316L (no) 2003-03-14
DE60143356D1 (de) 2010-12-09
CN100349575C (zh) 2007-11-21
JP4955896B2 (ja) 2012-06-20
CA2416990A1 (en) 2002-01-31
US7141554B2 (en) 2006-11-28
WO2002007533A2 (en) 2002-01-31
BG107473A (bg) 2004-07-30
EP1305036A2 (en) 2003-05-02
EP1305036B1 (en) 2010-10-27
EP2255815A2 (en) 2010-12-01
KR20030041962A (ko) 2003-05-27
ZA200301401B (en) 2004-05-21
US20050053641A1 (en) 2005-03-10
IL153989A (en) 2005-08-31
IL153989A0 (en) 2003-07-31
PT1305036E (pt) 2011-01-28
CN1466459A (zh) 2004-01-07
BRPI0112685B1 (pt) 2020-04-07
HUP0303728A2 (hu) 2004-03-29
ATE485827T1 (de) 2010-11-15
AU2001289680A1 (en) 2002-02-05
CA2416990C (en) 2010-09-14
EP2204176A3 (en) 2010-07-14
DK1305036T3 (da) 2011-02-07
WO2002007533A3 (en) 2002-04-11
US20030166610A1 (en) 2003-09-04
EP2204176A2 (en) 2010-07-07
EP2255815A3 (en) 2012-07-11
PL366049A1 (en) 2005-01-24
EP1175905A1 (en) 2002-01-30
NO20030316D0 (no) 2003-01-21
ES2355754T3 (es) 2011-03-30
MXPA03000742A (es) 2003-09-25
HUP0303728A3 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
BR0112685A (pt) Composição nutricional
BR0214838A (pt) Composição para promoção de crescimento ósseo e manutenção da saúde óssea
BR0317747A (pt) Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave
BR0212985A (pt) Uso de pyy ou de um agonista do mesmo na preparação de medicamentos para tratamento de distúrbios associados com excesso de peso
BRPI0416809A (pt) glicosamina
BR9810832B1 (pt) composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais.
PL323364A1 (en) Bicyclic aromatic compounds
DE69622855D1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
BR0008879A (pt) Produto alimentìcio de animal de estimação, processo para preparar o mesmo, método para alimentar um animal, uso de fibra de endosperma de coco, e, métodos para a prevenção ou para o tratamento de uma infecção bacteriana patogênica no intestino grosso de um animal de estimação e de inflamação intestinal em um animal
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
EP1393738A4 (en) MEDICINE AGAINST DIABETES
BR9915071A (pt) Utilização de uma proteìna ompa de enterobactéria ou de um de seus fragmentos
BR9907234A (pt) Polìmeros ligantes de gordura
BR0111371A (pt) Uso de um gênero de bactéria láctica exógena contra doenças actinomyces naeslundii-relacionadas
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
FR2842425B1 (fr) Utilisation d'extraits de ginkgo biloba pour favoriser la masse musculaire au detriment de la masse graisseuse
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
BRPI0403363A (pt) relaxantes musculares seletivos e composições farmacêuticas
BR0207124A (pt) uso de alimta, pacote terapêutico para dispensação a,ou uso na dispensação a, um paciente sendo tratado para hcmv, e, artigo de manufatura
BR9806851A (pt) ComposiçÊes farmaceuticas e alimenticias que contêm bactérias de gênero acetobacter

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/70 (2006.01), A23L 1/052 (2006.01), A23L 1

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/70 (2006.01), A23L 29/244 (2016.01), A23L

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2628 DE 18-05-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.